Manufacturing

Zydus’ manufacturing capabilities span the pharmaceutical value chain, supporting a broad range of products across formulations, intermediates and APIs. Backed by integrated infrastructure, specialised development capabilities and a strong focus on quality, the network enables efficient scale up and reliable supply across diverse therapy areas and dosage forms.

Formulations

Its formulations capabilities include oral dosage forms such as tablets, hard and soft gel capsules; injectables including sterile liquids and lyophilised products; as well as inhalers, transdermals, suppositories and vaccines. Zydus also undertakes formulation development for ANDA candidates through a dedicated Pharmaceutical Technology Centre and has capabilities in developing specialised dosage forms.

Intermediates and APIs

Across intermediates and APIs, Zydus manufactures specialty chemicals, fine chemicals, advanced intermediates, high-end bulk actives and investigational bulk actives. These capabilities reinforce its integrated presence across the value chain and support the development and supply of high-quality healthcare solutions across markets.